feed,title,long_url,short_url
Benzinga,Novartis Inks Option Agreement For BeiGene Anti-Cancer Therapy For Over $1B,https://benzinga.com/general/biotech/21/12/24694920/novartis-inks-option-agreement-for-beigene-anti-cancer-therapy-for-over-1b,https://j.mp/3F9jlHr
Benzinga,"Lineage, Genentech Ink Cell Therapy Licensing Pact For Ocular Diseases",https://benzinga.com/general/biotech/21/12/24694311/lineage-genentech-ink-cell-therapy-licensing-pact-for-ocular-diseases,https://j.mp/3yK0Maf
